Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The NIH 3T3 cell transformation assay identifies transfectable oncogenes in tumor DNA.
• The EJ oncogene (c-Ha-ras1) from human bladder carcinoma is closely related to v-Ha-ras.
• A single point mutation in c-Ha-ras1 confers transforming potential.

Purpose of the Study:

• To investigate the transforming effects of the EJ oncogene in a hamster fibroblast system.
• To understand the role of cellular immortalization in oncogene-induced transformation.
• To examine oncogene activity in the context of multi-stage carcinogenesis.

Main Methods:

• Transfection of the EJ oncogene into normal and carcinogen-immortalized hamster fibroblasts.
• Utilizing a hamster fibroblast system designed for studying malignant transformation stages.
• Assessing the transforming activity of EJ c-Ha-ras-1 in cells with limited and extended lifespans.

Main Results:

• EJ c-Ha-ras-1 demonstrated incomplete transforming activity in normal, finite-lifespan fibroblasts.
• Complete transformation was achieved when EJ c-Ha-ras-1 was transfected into newly immortalized fibroblasts.
• This indicates that cellular immortalization is a critical factor for full oncogenic potential.

Conclusions:

• The EJ oncogene alone is insufficient for complete malignant transformation of normal fibroblasts.
• Cellular immortalization, induced by carcinogens, is necessary for the EJ oncogene to exert its full transforming capacity.
• These findings highlight the multi-stage nature of carcinogenesis, involving both oncogene activation and cellular changes.